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Methionine synthase is one of two key enzymes involved in the removal of the metabolite, homocysteine.
Elevated homocysteine levels constitute a risk factor
for cardiovascular diseases and for neural tube defects. In cell culture, the activity of methionine synthase is enhanced several-fold by supplementation
with its cofactor, B,,. The mechanism of this regulation is unknown, although it has been ascribed to a
shift from apoenzyme to holoenzyme. Using sensitive
assay techniques as well as a combination of Northern
and Western analyses, we demonstrate that the effect
of B,, on induction of methionine synthase activity is
paralleled by an increase in the level of the enzyme.
These studies exclude conversion of apoenzyme to holoenzyme as a basis for activation that had been described previously. Since the mRNA levels do not
change during the same period that the methionine
synthase levels increase, regulation of this protein by
its cofactor must be exerted posttranscriptionally.
0 1999 Academic Press

Methionine synthase is one of two key enzymes at
the homocysteine metabolic junction in mammalian
cell physiology. Its action converts homocysteine, a
toxic metabolite to methionine, and concomitantly
releases the circulating form of folic acid, methyltetrahydrofolate (CH,-H,folate), to tetrahydrofolate
(H,folate), that is then available for supporting DNA
biosynthesis (1,2).Elevated levels of homocysteine conThis work was supported by a grant from the National Institutes
of Health (DK45776) to R.B. and a Predoctoral Fellowship to S.G.
from the American Heart Association (Nebraska Affiliate).
Present address: 638C, Guggenheim, Mayo Clinic and Foundation, Rochester, MN 55905.
Corresponding author. Fax: (402) 472-7842. E-mail: rbanerje@
unlinfo2.unl.edu.
Abbreviations used: CH3-H,folate, methyltetrahydrofolate; H,folate,
tetrahydmfolate; SSC, saline sodium citrate; PBS, phosphate buffered
saline; EMEM,Eagle's minimum essential medium; DEPC, diethylpyrocarbonate; OHB,,, hydroxycob(II1)alamin; SDS, sodium dodecyl sulfate; MOPS, N-morpholinosulfonic acid.

stitute an independent and significant risk factor for
cardiovascular diseases (3).In addition, elevated levels
of homocysteine and low maternal levels of BIZ are
correlated with neural tube defects (4,5). Methionine
synthase is thus an important housekeeping enzyme at
the intersection of sulfur and one-carbon metabolism,
and its regulation influences intracellular homocysteine and folate pools. The consequences of lowering
homocysteine with vitamins are being measured in
clinical intervention studies. Thus, elucidating the
mechanism by which BIZinduces methionine synthase
activity and thereby affects homocysteine pools may
have an important bearing on these intervention
studies.
Studies by Mangum and North almost thirty years
ago on the regulation of mammalian methionine synthase in HEp-2 cells in culture revealed that supplementation of the medium with BIZresulted in a thirtyfold elevation of enzyme activity (6). This was later
extended to several other cell lines in which the BIZinduced activation of methionine synthase ranged from
10- to 30-fold (7). In the initial experiments, homocgsteine and vitamin BIZreplaced methionine and choline
in the medium. Homocysteine was however found to
have no effect on the activation of methionine synthase, since BIZin the presence or absence of homocysteine yielded the same extent of stimulation (7). The
activity of the only other mammalian BIZ-dependent
enzyme, methylmalonyl-CoA mutase, was unchanged
upon supplementation of the medium with BIZ(8).
Several alternative hypotheses can be considered to
explain induction of methionine synthase activity by
its cofactor, BIZ.First, if intracellular BIZconcentration
is limiting, increase in enzyme activity could be due to
conversion of apoenzyme to holoenzyme. Second, BIZ
may exert its regulation at the methionine synthase
promoter resulting in increased transcription. Third,
BIZ may enhance translation of the methionine synthase mRNA, either by affecting the stability of the
message or by increasing access of the message to the
translation apparatus. Fourth, B1, may enhance the
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stability of methionine synthase thereby affecting its
turnover in the cell. Finally, B,, may induce one or
more genes that in turn increases the level of methionine synthase either at a transcriptional or posttranscriptional level.
The recent cloning of the human methionine synthase cDNA (9-11) and the development of sensitive
assays to measure the relative apo- and holoenzyme
content of the enzyme (12-14) now permit evaluation
of these alternative hypotheses. In this study, we have
examined whether the induction of methionine synthase by B,, is correlated with changes in the mRNA
levels, protein levels or the percent holoenzyme. Our
studies clearly point to a post-transcriptional mechanism of activation of methionine synthase that is dependent on the synthesis of new enzyme.

RNA isolation. RNA was isolated using the RNeasy kit a s per the
vendor's protocol (Qiagen). Aliquots (20-30 pl) of RNA were stored a t
-80°C until needed.
Northern analysis. RNA samples (10-15 pg) were heated a t 65°C
for 5 min and then cooled immediately on ice prior to loading onto a
1% formaldehyde agarose gel. The gel was electrophoresed in RNase
free 1X MOPS (25 volts for -20 h a t 4"C), equilibrated with 10X SSC
and transferred to a Hybond N + membrane in the same buffer. After
overnight transfer, RNA was UV-linked to the membrane. Prehybridization and hybridizations were performed in Church and Gilbert hybridization buffer. Hybridization was conducted overnight a t
65°C for 12 h (with 3 x lo6 dpm per ml radiolabeled probe). An
NcoI-EcoRI fragment containing the homocysteine-binding domain
in plasmid SGHcy-28a (described below) was used a s one of the
probes. Probes (for methionine synthase and actin) were radiolabeled
with 32P (Rediprime kit from Amersham Life Science). Following
hybridization, the membrane was washed a t 65°C for 3 x 20 min
with 2X SSC and 0.1% SDS. The membrane was exposed to a phosphoimager screen for 2-3 days a t room temperature and then
scanned.

Cloning a n d expression of homocysteine binding domain of human
MS. The N-terminal region of human methionine synthase extending from amino acids 1 to 368 is homologous to the homocysteine
Materials. EMEM and hydroxocobalamin were purchased from binding domain of the E. coli protein ranging from residues 2-353
Sigma. Fetal calf serum was from Calbiochem. The RNeasy kit was (16,17). The segment of the human cDNA encoding this fragment
from Qiagen and Hybond N+ membrane was from Amersham. was amplified by PCR and cloned using the primers described below.
RNase free reagents (MOPS, SSC) were molecular biology grade and An NcoI site and a n EcoRI site were engineered into the 5' sense and
were purchased from 5 Prime-3 Prime. DEPC treated water was 3' antisense primers respectively and are indicated i n bold letters i n
used for making up solutions for RNA studies. Cell lines, Cos-7 the primer sequences shown below. 5' sense: 5' CATGCCAXGG(SV4O-transformed African Green Monkey kidney cells), HeLa (hu- CTCCGGCGCTGCAGGACCTGTCGC 3'. 3' antisense: 5' GAATTCman cervical carcinoma cells), HepG2 (human hepatoblastoma cells), AATGlTAACAAAlTACTAGTACGGTCCAATCCT 3'. In the 5' primer,
and 293 (transformed human kidney cells) cells were from ATCC, the E. coli codon preference was employed a t some locations to
and 293 t' (derivative of 293 expressing the T antigen) was from potentially enhance translation efficiency. The codon preference for
Mike Fudos (NIH). The actin probe was from a n in vitro transcrip- amino acids following the initiator methionine codon located within
tion kit from Ambion.
the NcoI site (underlined in primer sequence) are indicated in paCell culture. Cells were cultured in EMEM supplemented with rentheses: Met-Ala (E. coli)-Pro (E. co1i)-Ala (human)-Leu (E. co1i)10% fetal bovine serum and maintained a t 37"C, 5% CO,. The con- Gln (E. co1i)-Asp (human)-Leu (human)-Ser (human). In the 3'
centration of folic acid and methionine i n this medium are 2.3 pM primer, two tandem stop codons (underlined) were engineered into
and 100 pM respectively. The estimated concentration of BIZin the the sequence after residue 368 encoding tyrosine. A 1.1kb fragment
unsupplemented medium is -125 pM, and is derived from the serum was amplified by PCR using Klentaq polymerase (Clonetech) and
(15). For studies involving RNA isolation, confluent cells from 4 or 5 cDNA from human pancreas (Clonetech) a s template. The amplified
petri dishes (150 mm) were harvested and frozen in lysis solution band was initially cloned into the TA vector, PCR 2.1, from Invitrogen, and the ligation mixture was used to transform E. coli Top10 F'
and stored a t -80°C until further processing.
For studies involving protein analysis (enzyme assays or Western cells (Invitrogen). DNA from a single colony was digested with NcoI
blots) cell monolayers were washed with PBS, collected by centrifu- and EcoRI and the fragment was cloned into the pet 28 a expression
gation and the pellet was washed twice with PBS prior to freezing a t vector (Novagen) to create SGHcy-28a, and transformed into BL21
-80°C. For B,, induction studies, cells were grown to subconfluency DE3. The DNA sequence of the insert in SGHcy-28a was determined.
before replacement of the medium with fresh EMEM supplemented
Expression of homocysteine binding domain of human methionine
with OHBIZa t a concentration of 5 mg/L. The BIZconcentration was synthase. A colony containing plasmid SGHcy-28a with the 1.1kb
chosen based on the dose response for methionine synthase activity insert, was grown overnight i n 2 ml LB medium (containing 50 pglml
that has been reported previously (15). For experiments i n which kanamycin) which was used to inoculate a 50 ml LBkanamycin
methionine synthase activity, and protein and RNA levels were culture the next day. The culture was grown a t 37°C to a n O.D,,, of
being determined simultaneously a t fixed time points following BIZ 0.5-0.6 (-3 h) and expression was induced with 0.8 mM IPTG for 3 h.
addition (0, 24, and 48 h), a large number of plates were cultured in Cells were collected by centrifugation and the pellet was resusparallel. Cells from 3 or 4 petri dishes were used per time point for pended in 3 ml of 50 mM Tris-HC1 pH 8.0,2 mM EDTA. The soluble
each of the protein and RNA determinations.
and insoluble cell fractions were obtained using a protocol from
Methionine synthase assay using cell extracts. The cell extracts Novagen. Lysozyme a t a concentration of 100 pglml and 0.1 volume
were prepared and anaerobic assays were performed essentially as of 1% Triton X-100 (Bio-Rad) were added to the resuspended pellet
described previously (13). The cell extracts for the assays were and incubated a t 30°C for 15 min. This was followed by centrifugathawed immediately prior to their use. They were made anaerobic by tion a t 12,000 X g for 15 min a t 4°C. The soluble (supernatant) and
gently passing N, for 30 min over the extracts in 1.5 ml eppendorf insoluble (pellet) fractions were resuspended in a 1X SDS sample
tubes sealed with red rubber septa. The amount of protein used in loading buffer (Bio-Rad) containing P-mercaptoethanol, and sepathe assays ranged from 0.3 mg to 0.6 mg. Protein concentrations rated by electrophoreses on a 10% SDS polyacrylamide gel (Figure
were determined using the Bradford assay (BioRad) with bovine 3A). The identity of the recombinant 37 kDa band was confirmed by
serum albumin a s standard. One unit of activity is defined a s the N-terminal amino acid sequence analysis and by Western analysis
using antibodies generated against porcine methionine synthase
amount of protein required to synthesize one pmol of methionine h-'
(12). DNA and N-terminal sequence analyses revealed that Glu 12
a t 37°C.

MATERIALS AND METHODS
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TABLE I

Induction of Methionine Synthase Activity by B,, in Cell Culture
Medium:
Specific activity
Cell line

-BIZ

+Biz

Specific activitya
%Holo

-BIZ

+Biz

%Holo

Fold increaseb

C0S7
HeLa
293t+
HepG2
293
" Specific activity is expressed in pmol methionine formed min-' mg-' a t 37°C.
The fold increase was estimated by comparing the values for specific activities measured i n the presence of added BIZ.

was deleted. This could have resulted from a polymorphism a t this
position that was present in the cDNA library or, more likely, from a
PCR error.
Generation of antibodies against the human methionine synthase.
The pellet containing the insoluble N-terminal domain of human
methionine synthase was washed extensively with 50 mM Tris, pH
8.0 containing 2 mM EDTA. The washed pellet (-1.5 mg) was separated on a preparative 7% SDS polyacrylamide gel and the band of
interest was excised after staining with Coommasie brilliant blue
R-250 (Bio-Rad) followed by extensive destaining. The excised band
was sent to a commercial antibody facility (Alpha Diagnostics,
Texas) for generation of polyclonal antibodies i n rabbits.
Western analysis of human methionine synthase in cells cultured in
medium ? B,,. Extracts (50 bg protein), from cells grown in EMEM
medium supplemented with B,, for 0.24 and 48 h. were separated on
a 5% SDS ~olyacrylamidegeir The 'proteins were transferred to a
PVDF membranes using a tank electroblotter for 6 h a t 100 V.
Western analysis was performed using a 1:100 dilution of the first
antibody and a 1:5000 dilution of the second antibody, anti-rabbit
IgGIalkaline phosphatase conjugate (BioRad), followed by chemiluminescent detection using the CDP-Starr kit (Tropix). Chemiluminescent signals were quantitated using a Molecular Dynamics densitometer.

RESULTS

Induction of methionine synthase activity by Biz is
not due to apoenzyme to holoenzyme conversion. In
order to examine whether or not activation by B,, is
due to conversion of apoenzyme to holoenzyme, the
effect of B,, addition to the cell culture medium was
examined in five different cell lines (Table I). Enzyme
activity was measured in the anaerobic titanium citrate assay either in the presence or absence of exogenous B,,. Activity determined in the presence of B12
represents total methionine synthase activity. In the
absence of B,,, only holoenzyme activity is measured.
Thus the ratio of activity observed in the absence to
that in the presence of additional cofactor represents
the proportion of holoenzyme present. As shown in
Table I, all five cells lines showed stimulation of methionine synthase activity when the medium was supplemented with B,,. The fold increase varied with the
cell line, ranging from 2-fold in HeLa cells to - 14-fold

in HepG2 cells. Increasing the concentration of the
cofactor ten-fold did not further increase the foldinduction (data not shown). Comparison of enzyme activity from cells that had been supplemented with B,,
with those grown in unsupplemented media show that
the proportion of holoenzyme remained the same,
within experimental error. The only exception was
293t' cells where the holoenzyme content increased
from 34% to 100%. However, the 3-fold increase in
percent holoenzyme does not account for the almost
6-fold increase in methionine synthase activity resulting from B,, supplementation. 293 cells were employed
for the remainder of the studies described below because of their high holoenzyme content and rapid
growth rate.
Kinetics of methionine synthase induction by B,,.
The time course for the activation of methionine synthase was examined next. As shown in Figure 1, increase in methionine synthase activity could be observed as early as two hours following B,, addition. The
activity increased rapidly during the first six hours
reaching a plateau in -24 to 48 h and was sustained
until 72 h.

B,, supplementation does not change methionine synthase RNA levels. To examine whether the B,, effect
is due to transcriptional activation of the methionine
synthase gene, mRNA levels were analyzed 0, 24 and
48 h after addition of the cofactor (Figure 2A). Two
methionine synthase mRNA's of -10 and 7.5 kb sizes
were observed by Northern analysis as has been reported previously (9,ll). However, the level of methionine synthase mRNA remained unchanged during the
same period that a 2.5-fold increase in enzyme activity
was observed. Equal loading of RNA in the three lanes
was confirmed by probing for the actin message (Figure
2B). Northern analysis of three other cell lines (COST,
HepG2 and 293t') also revealed that the methionine
synthase mRNA levels do not change upon B,, supplementation (data not shown).

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Vol. 259, No. 2, 1999

0

10

20

30

40 50

60 70 80

FIG. 2. Northern blot analysis of RNA from 293 cells, 0, 24, and
48 h after addition of B,,. RNA was isolated and detected by Northern blot analysis as described under Materials and Methods. (A) Two
bands corresponding to the -10 kb and 7.5 kb methionine synthase
cDNA forms were observed. (B) To confirm equal loading of RNA in
the lanes, the blot was later probed for the actin message.

Tie, h

FIG. 1. Kinetics of methionine synthase induction in 293 cells by
B,,. cells were grown to subconfluencyin 150 mm petridishes as
described under Materials and Methods. The medium was aspirated
off and replaced with fresh EMEM with either ? B,,. The cells were
harvested by scraping at the indicated time points and frozen until
further analysis. Methionine synthase activity was determined in
the anaerobic titanium citrate assay in the absence of additional
cobalamin. The time points were repeated in either duplicate or
triplicate, and standard errors are indicated.

number of nutrients function as cofactors or substrates a t
the homocysteine metabolic junction. Cystathionine
P+,pthase is a vitamin B,- and heme-dependent enzyme
whereas met.onine synthase requiresboth B,, and a
folate derivative, CH,-H,folate, for activity. This has recently led to the promotion of a multivitamin tablet containing B,, BIZ,and folic acid as a '%omocysteine defense"

Western analysis of methionine synthase levels in cell
cultures exposed to B,,. Cell extracts from the 0, 24
and 48 h time points were analyzed by Western blotting. As shown in Figure 3B, an increase in methionine
synthase level is observed between the 0 and 24 h time
points, while the difference between the 24 and 48 h
time points is negligible. To ensure equal loading, the
membrane was also exposed to antibody generated
against the P. shermanii methylmalonyl-CoA mutase.
As expected, the levels of this protein did not exhibit a
time dependent change (Figure 3B lower panel). An
additional lower band also crossreacted with the mutase antibody. Although its identity is unknown (it may
be a proteolytic form), it serves as an additional control
to demonstrate that a specific increase in methionine
synthase levels is observed on supplementation of the
medium with B,,.
DISCUSSION

Elevated concentrations of homocysteine are correlated with risk for two apparently unrelated pathologies:
cardiovascular diseases (3) and neural tube defects (5). In
mammalian cells, two major enzymatic routes detoxify
homocysteine. Transmethylation, catalyzed by either methionine synthase or betaine homocysteine methyltransferase, salvages homocysteine to the AdoMet-dependent
methylation cycle. Transsulfuration, catalyzed by cystathionine P-synthase converts homocysteine to cystathionine, and represents the first step in its catabolic removal. Due to the limited tissue distribution of betaine
homocysteine methyltransferase in the liver and kidney
(18),methionine synthase is the major transmethylase. A

B

FIG. 3. Overexpression of human methionine synthase fragment
and Western analysis of methionine synthase at various time points
following addition of Biz. (A) Overexpression of the homocysteinebinding domain of human methionine synthase. Cell extracts containing SGHcy-28a were prepared as described under Materials and
Methods. Lane 1has low molecular weight markers, lane 2 has cell
extract after sonication, lanes 3 and 4 have the soluble and insoluble
fractions respectively separated from the cell extract. (B) Western
analysis of methionine synthase levels in the 293 cell extracts at the
indicated time points. As a control, the membrane was also probed
with antibodies generated against methylmalonyl-CoA mutase from
Propionibacterium shermanii. The band indicated by an arrow corresponds to the human mutase. MS refers to methionine synthase.
The sizes of the molecular weight markers (in kDa) are indicated on
the left.
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formula, and to folic acid fortification of flour in the U.S.
in an effort to reduce the incidence of neural tube defects.
Homocysteine lowering intervention studies using different vitamin regimens are either imminent or ongoing in
several countries.
Understanding the role of cofactors in regulating the
activities of enzymes at the homocysteine metabolic
junction is therefore of importance from a clinical
standpoint. One of these cofactors, B,,, was described
thirty years ago, to induce activity of methionine synthase in cell culture (6). In this study we have also
observed that B,,-induces a 2 to 14-fold increase in
methionine synthase activity in different cell lines. The
mechanism by which exogenous B,, in the cell culture
medium causes an increase in methionine synthase
activity was previously unknown, although it had been
ascribed to conversion of preexisting apoenzyme to holoenzyme (8,15).
However, evaluation of the percent holomethionine
synthase is complicated by its existence in multiple
oxidation states, containing B,, as methylcob(II1)alamin, hydroxycob(III)alalmin or cob(I1)alamin. Of
these, only the first is active under i n vitro assay conditions, and then only, for a limited number of turnovers (100-2000 depending on the degree of anaerobiocity (19,20)).This results from the oxidative sensitivity
of the cofactor intermediate, cob(I)alamin,under catalytic turnover conditions. The oxidized forms of the
enzyme can be reactivated in the presence of a one
electron donor and S-adenosylmethionine. The standard i n vitro assay employs dithiothreitol and OHB,,
as a source of electrons. In the absence of OHB,,, dithiothreitol is unable to transfer electrons to methionine synthase (21). The problem with this assay arises
from its dependence on OHB,,, which serves both to
transfer electrons from dithiothreitol to activate oxidized holoenzyme and binds to apoenzyme, eventually
converting it to holoenzyme (12). Thus, the complexity
of the methionine synthase assay has resulted in significant underestimation of the holoenzyme content in
the literature.
This problem is addressed by employing titanium
citrate as the electron donor since it can directly reduce
methionine synthase (12). Under these assay conditions, the relative content of apo- and holoenzyme can
be evaluated by measuring activity in the presence and
absence of exogenous OHB,,. Using this assay, we
demonstrate that the increase in methionine synthase
activity is not correlated with conversion of apoenzyme
to holoenzyme (Table I). In fact in four of the five cell
lines, addition of B,, to the cell culture medium does
not affect the level of holomethionine synthase at all.
One exception, 293t' cells, show a 3-fold increase in
holoenzyme under these conditions, although this is
insufficient to account for the 5.7-fold increase observed in methionine synthase activity. These results
necessitate evaluation of alternative mechanisms to
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FIG. 4. Comparison of the methionine synthase activity and
RNA and protein levels a t the indicated time points following addition of B,, to the medium.

account for B,, induction of methionine synthase
activity.
The recent cloning of the human methionine synthase cDNA permits direct evaluation of the mRNA
levels as a function of time following exposure to B,,. In
order to choose appropriate time points for this analysis, the kinetics of methionine synthase induction were
studied in the 293 cell line. As shown in Figure 1,
maximal activation is observed in -24 h, and this level
is sustained up to 72 h. This is very similar to the
kinetics reported in cultured BHK cells (15). Based on
these data, we compared the mRNA and protein levels
at 0, 24 and 48 h following B,, addition to the cell
culture medium (Figure 3). Comparison of the ratio of
methionine synthase mRNA to actin mRNA indicates
that the level of the methionine synthase mRNA remains fairly constant over 48 h (Figure 4) during which
time enzyme activity increases 2.5-fold. The two RNA
bands that hybridize to the methionine synthase probe
have been observed previously (9,ll). The shorter
cDNA has been sequenced completely (9). The 10 kb
band is apparently a preprocessed form of the 7.5 kb
message, since it hybridizes to a probe complementary
to intron 5 (11).
Since activation of methionine synthase levels was
reported to be due to conversion of apoenzyme to holoenzyme we have directly estimated the relative levels
of methionine synthase protein in the presence and
absence of added B,,. As seen in Figures 3B and 4, an
increase in the steady-state concentration of methionine synthase parallels the increase in its activity. It
was previously reported that B,, induction of methionine synthase activity was not affected by the presence
of the translation inhibitor, puromycin, added simultaneously with B,, to the cell culture medium (15). However, these results were inconsistent with the kinetics
of B,, activation in the BHK cell lines reported in the
same paper, since in the presence of puromycin, full
activation was observed in 12 h rather than in 24 h.
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Additionally, B,, has a very high affinity transport
system, it is possible that the rate of B,, import was
more rapid than that of puromycin, resulting in a delayed effect of puromycin. In contrast, western analysis
permits a more direct evaluation of methionine synthase levels, and demonstrates unambiguously that a
new protein synthesis is required for activation by B,,.
At least two alternative hypotheses can be considered to explain the mechanism of B,, induced activation of methionine synthase. First, the intracellular B,,
pool increases upon supplementation of the medium
and a higher proportion of newly synthesized methionine synthase is stabilized by binding cofactor. While
our data do not rule this out, it seems unlikely since the
levels of holoenzyme do not change significantly in
most cell lines. For example 66% of methionine synthase in Cosy cells is present in the holoenzyme form
regardless of whether or not the medium is supplemented with the cofactor. If stabilization of methionine
synthase by an increased intracellular B,, pool resulted in the increase in its steady-state levels, the
percentage of holoenzyme would have been expected to
be increased.
Alternatively, methionine synthase could be translationally regulated by its cofactor. Two other folatedependent enzymes, dihydrofolate reductase and thymidylate synthase (22-24), bind to their own mRNAs.
This represses translation and represents a form of
autoregulation. Binding of the nucleotide substrate
(dUMP in thymidylate synthase) or cofactor (NADPH
in dihydrofolate reductase) competes with binding for
mRNA and alleviates translation inhibition. This has
led to the suggestion that the nucleotide binding domains of RNA-binding proteins may have acquired enzymatic activity (or the converse) during evolution (25).
It is interesting to note that B,, also has a nucleotide
moiety, with an unusual base, dimethylbenzimidazole,
that is appended from ring D of the corrin macrocycle.
Vitamin B,, has been shown to mediate repression of
gene expression in E. coli and in Salmonella typhimurium. In the latter organism, expression of the cob
operon involved in the de novo biosynthesis of B,, is
repressed (26-28). In both E. coli and in S . typhimurium, B,, represses the btuB gene product encoding
an outer membrane B12transport protein (29,30). Studies on the mechanism of this repression reveal that it is
mediated postranscriptionally (31). A 25 bp long regulatory sequence designated as the B,, box is located
-80-110 bp upstream of the initiation codon, and has
been suggested to constitute the binding site of B,,
itself or a B,, responsive protein (27). In addition, a
second common element observed in these transcripts
is the presence of sequences in the leader with the
potential to form an RNA hairpin which sequesters the
RNA binding site. In the presence of B,, an RNA hairpin forms with inhibits translation initiation of the
cbiA gene in S . typhimurium (28). Since the regulatory

elements for translation are distinct in prokaryotes
and eukaryotes, it is not surprising that a consensus
B,, box is not observed in the human methionine synthase cDNA.
In summary, our data exclude both conversion of
apomethionine synthase to holoenzyme and transcriptional activation as explanations for the observed induction of methionine synthase activity by its cofactor,
B,,. Instead, our data demonstrate that induction of
methionine synthase activity correlates with increased
levels of protein, and is therefore exerted a t a posttranscriptional level. Elucidation of the mechanism of B,,mediated posttranscriptional regulation will be the
subject of future investigation.
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